Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Emil Wolsk; Brian Claggett; Rafael Díaz; Kenneth Dickstein; Hertzel C. Gerstein; Lars Køber; Francesca Lawson; Eldrin F. Lewis; Aldo Maggioni; John J.V. McMurray; Jeffrey L. Probstfield; Matthew C. Riddle; Scott D. Solomon; Jean‐Claude Tardif; Marc A. Pfeffer

doi:10.1161/circulationaha.117.029503

Article2017

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Emil Wolsk, Brian Claggett, Marc A. Pfeffer, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Francesca Lawson, Eldrin F. Lewis, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif, Lars Køber

Article2022

Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The <scp>ELIXA</scp> trial

Hertzel C. Gerstein, Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Marc A. Pfeffer

Article2020

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

Magnus Wijkman, Brian Claggett, Rafael Díaz, Hertzel C. Gerstein, Lars Køber, Eldrin F. Lewis, Aldo Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley–Lewis, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Scott D. Solomon, Marc A. Pfeffer

Preprint2022

Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"

Hertzel C. Gerstein, Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Marc A. Pfeffer

Preprint2022

Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"

Hertzel C. Gerstein, Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Marc A. Pfeffer

Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Discussion(0)

Related publications

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The <scp>ELIXA</scp> trial

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"

Author response for "Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial"